Maze Therapeutics, Inc. logo

MAZEMaze Therapeutics, Inc.

MAZE Stock Price, Valuation & Chart | Maze Therapeutics, Inc.

Compare
$31.370-1.06 (-3.27%)

At close · 20 Nov 2026, 08:59 pm

MAZE Historical price chart

MAZE Key Stats

Fair value estimate
Disclaimer

General advice only. Model estimate, not a price target or a recommendation to buy, sell or hold. Not based on your objectives, financial situation or needs: consider the product disclosure statement and your own circumstances. Alphacentric Technology Pty Ltd t/a Tickerplace is a CAR (No. 001324046) of MF & Co. Asset Management Pty Ltd (AFSL 520442).

Market Capitalization1.72B
PE Ratio-12.4
EPS-2.53
Trading Volume664.54K
Today's High/Low32.72/31.1
Dividend Yield0.00
52 Week High/Low53.65/21.95
Shares Outstanding54.68M

Price and calculated levels

A preview of the MAZE chart Pro members see. Dollar amounts stay locked. Each line is a calculated margin of safety or premium price, not a forecast.

Price $•••$•••+100%$•••+90%$•••+80%$•••+60%$•••+40%$•••+20%$•••Fair value$•••−20%$•••−30%$•••−40%$•••−50%$•••−60%
MAZE Financial Statement
MAZE Analyst ratings
MAZE Analysis & performance metrics

MAZE Company profile

Maze Therapeutics, Inc., a clinical stage biopharmaceutical company, develops small molecule precision medicines for the treatment of renal, cardiovascular, related metabolic…

MAZE Management team

Management
Courtney J. Phillips J.D.
General Counsel & Corporate Secretary
Amy BachrodtCFO
Senior Vice President of Finance & Chief Financial Officer
Nazila Habibizad
Senior Vice President of Technical Operations & Supply Chain
Jason V. Coloma M.B.A., M.P.H., Ph.D.CEO
Chief Executive Officer & Director
Vipin Vijayakumar
Vice President of R&D Infrastructure and Operations
Maarten Hoek
Senior Vice President of Research
Winston Tse
Senior Vice President of Drug Discovery
Atul Dandekar
Chief Strategy & Business Officer
Total 8 executives

MAZE Frequently asked questions

What is Maze Therapeutics, Inc. (MAZE) Stock Price?

Current stock price of Maze Therapeutics, Inc. (MAZE) stock is $31.370. The stock price is -3.27% lower in the session. The intraday range can be seen from this page. Volume of Maze Therapeutics, Inc. (MAZE) stock is 664.54K.

Last updated at 20 Nov 2026, 08:59 pm.

Why is the Maze Therapeutics, Inc. (MAZE) stock price going up or down today?

The stock price of Maze Therapeutics, Inc. (MAZE) can change with earnings, company news, and overall market sentiment. Maze Therapeutics, Inc. operates in the Healthcare / Biotechnology market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.

Is the Maze Therapeutics, Inc. stock expensive at its current price?

Whether Maze Therapeutics, Inc. looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for MAZE on this page is -12.40. EPS on this page is -2.53. Compare those figures with peers and growth expectations before deciding if the current Maze Therapeutics, Inc. price is justified.

How has the stock price of Maze Therapeutics, Inc. (MAZE) performed historically?

Historical performance for Maze Therapeutics, Inc. (MAZE) is shown on the price chart on this page. Review multi-period moves alongside volume to see how MAZE reacted to past earnings and market events.

Should I buy Maze Therapeutics, Inc. (MAZE) stock, at this price?

Buying Maze Therapeutics, Inc. (MAZE) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.